Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-19

Clinical Trial Update: Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis

View source ↗

Summary

This clinical trial update reports on the completed study assessing LDL cholesterol as a cardiovascular disease risk factor in patients with rheumatoid arthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arkansas | Conditions: Rheumatoid Arthritis, Cardiovascular Disease | Status: COMPLETED